ProQR Therapeutics (PRQR) Asset Utilization Ratio (2014 - 2026)
ProQR Therapeutics (PRQR) posted quarterly Asset Utilization Ratio of 0.13 for Q1 2026, up 6.75% year-on-year from 0.12 in Q1 2025, and down 5.54% on a QoQ basis from 0.13 in Q4 2025.
ProQR Therapeutics (PRQR) Asset Utilization Ratio (2014 - 2026) Analysis & Trends
ProQR Therapeutics (PRQR) has reported Asset Utilization Ratio for 12 consecutive years, with 0.13 the latest figure, recorded in Q1 2026.
- Quarterly Asset Utilization Ratio rose 6.75% year-over-year to 0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.13 (up 6.75% YoY) and the FY2025 annual result came in at 0.11, down 8.33% from the prior year.
- Asset Utilization Ratio fell to 0.13 in Q1 2026 per PRQR's latest filing, from 0.13 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for PRQR reached as high as 0.16 in Q3 2024 and fell as low as 0.01 in Q1 2022.
- A 5-year average of 0.08 and a median of 0.08 in 2024 frame the typical range for Asset Utilization Ratio.
- The largest YoY upside for Asset Utilization Ratio was 2159.57% in 2022 against a maximum downside of 85.12% in 2022.
- Year by year, Asset Utilization Ratio stood at 0.02 in 2022, then surged by 89.75% to 0.05 in 2023, then jumped by 195.62% to 0.14 in 2024, then fell by 2.48% to 0.13 in 2025, then dropped by 5.54% to 0.13 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.13, 0.13, and 0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ProQR Therapeutics | 219.53 Mn | 175.72 Mn | - | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.11 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.16 |
| Jun 30, 2024 | 0.13 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.03 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.00 |